𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: Rationale and design of the Counterpulsation Reduces Infarct Size Acute Myocardial Infarction trial

✍ Scribed by Manesh R. Patel; Holger Thiele; Richard W. Smalling; Praveen Chandra; Yi Zhou; Marc Cohen; Divaka Perera; Erik Magnus Ohman

Book ID
116192490
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
441 KB
Volume
162
Category
Article
ISSN
1097-6744

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)
✍ Ik-Kyung Jang; Neil J. Weissman; Michael H. Picard; Michael R. Zile; Veronica Pe πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 264 KB
Design and rationale for the Myocardial
Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: A multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction
✍ NoΓ©mi Nyolczas; Mariann GyΓΆngyΓΆsi; Gilbert Beran; Markus Dettke; Senta Graf; Hei πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier Science 🌐 English βš– 244 KB
A Randomized, Double-Blind, Placebo-Cont
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study
✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D πŸ“‚ Article πŸ“… 2005 πŸ› Springer US 🌐 English βš– 219 KB
Rationale and design of the Anti-Xa Ther
Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome
✍ C. Michael Gibson; Jessica L. Mega; Paul Burton; Shinya Goto; Freek Verheugt; Ch πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier Science 🌐 English βš– 428 KB